Schwab Charles Corp (SCHW): who owns it and who trades it
As of Nov 16, 2026, SCHW insiders reported 92 open-market sales worth $347M and 1 purchase worth $1.8M in the last 12 months, with 10% of the sale value made under pre-set 10b5-1 plans. The largest seller was Charles R. Schwab (Chair), with $201M. 11 of the 50 famous funds we follow held it at their last quarter end.
Latest filing Nov 16, 2026. From Form 4, 13F and Schedule 13D/G filings.
At a glance
Who is buying and selling Schwab Charles
From the latest filingsOverall: more selling than buying. Insiders mostly sold. Funds and famous investors were close to even.
Each group counts equally in the meter, by the number of buyers and sellers, not dollars. Insider sales under pre-set 10b5-1 plans are left out of it. From SEC, House and Senate filings; not advice.
Who owns SCHW
2,297 funds and institutions reported SCHW shares worth $134B at the end of Q2 2026, about 83% of the company. The largest holder is BlackRock, Inc. with 7.7%.
Funds and institutions (13F) 83%Everyone else 17%
10 largest owners, by share of the company
Top 20 owners
| Owner | Shares | % of company | Value | Change since Q1 2026 |
|---|---|---|---|---|
| BlackRock, Inc. | 134.41M | 7.73% | $12.4B | +1% |
| Vanguard Capital Management LLC | 107.33M | 6.17% | $9.9B | -1% |
| Dodge & Cox | 76.97M | 4.43% | $7.1B | +3% |
| State Street Corp | 73.17M | 4.21% | $6.8B | +1% |
| JPMorgan Chase & Co | 49.17M | 2.83% | $4.5B | – |
| FMR LLC (Fidelity) | 44.27M | 2.55% | $4.1B | +24% |
| T. Rowe Price Associates | 43.29M | 2.49% | $4B | -11% |
| Geode Capital Management, LLC | 37.29M | 2.14% | $3.4B | -4% |
| Franklin Resources Inc | 36.48M | 2.10% | $3.4B | +15% |
| Vanguard Portfolio Management LLC | 26.89M | 1.55% | $2.5B | +1% |
| Primecap Management Co | 25.12M | 1.44% | $2.3B | +7% |
| Harris Associates L P | 24.20M | 1.39% | $2.2B | +11% |
| Morgan Stanley | 22.79M | 1.31% | $2.1B | +3% |
| Norges Bank | 22.66M | 1.30% | $2.1B | – |
| Fisher Asset Management, LLC | 21.95M | 1.26% | $2B | -1% |
| Artisan Partners Limited Partnership | 18.93M | 1.09% | $1.7B | +8% |
| Bank of America Corp | 15.99M | 0.92% | $1.5B | +2% |
| Northern Trust Corp | 15.95M | 0.92% | $1.5B | -2% |
| Massachusetts Financial Services Co | 13.36M | 0.77% | $2.1B | -8% |
| Invesco Ltd. | 13.09M | 0.75% | $1.2B | -23% |
From the SEC 13F data sets: every fund manager with over $100M must report its US stock holdings every 3 months, up to 45 days after the quarter ends. Owners are shown as they file, so one group (for example Vanguard) can appear under several names. Individuals, most insiders and smaller funds do not file 13F reports.
Insider trades
In the last 12 months, SCHW insiders reported $1.8M of open-market purchases and $347M of sales. 10% of the sale value was under a 10b5-1 plan, a schedule set up in advance.
Purchases and sales by month
Latest trades
| Date | Insider | Role | Type | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|---|
| Nov 9, 2026 | Charles R. Schwab | Chair | Sale | 70,750 | $93.01 | $6.6M | Form 4 |
| Nov 3, 2026 | Charles R. Schwab | Chair | Sale | 11,675 | $89.21 | $1M | Form 4 |
| Nov 2, 2026 | Neesha Hathi | MD | Sale plan | 5,000 | $88.92 | $445K | Form 4 |
| Oct 29, 2026 | Charles R. Schwab | Chair | Sale | 136,400 | $89.50 | $12.2M | Form 4 |
| Oct 28, 2026 | Charles R. Schwab | Chair | Sale | 66,750 | $88.36 | $5.9M | Form 4 |
| Oct 1, 2026 | Neesha Hathi | MD | Sale plan | 5,000 | $97.80 | $489K | Form 4 |
| Sep 1, 2026 | Neesha Hathi | MD | Sale plan | 3,177 | $109.04 | $346K | Form 4 |
| Aug 28, 2026 | Walter W Bettinger | Chair | Sale | 74,388 | $110.91 | $8.3M | Form 4 |
| Aug 28, 2026 | Neesha Hathi | MD | Sale plan | 3,177 | $108.12 | $343K | Form 4 |
| Aug 26, 2026 | Carolyn Schwab-Pomerantz | Director | Sale | 9,175 | $109.25 | $1M | Form 4 |
| Aug 24, 2026 | Charles R. Schwab | Chair | Sale | 117,000 | $113.20 | $13.2M | Form 4 |
| Aug 24, 2026 | Walter W Bettinger | Chair | Sale | 176,210 | $113.49 | $20M | Form 4 |
| Aug 17, 2026 | Jonathan S Beatty | MD | Sale | 1,000 | $111.33 | $111K | Form 4 |
| Aug 14, 2026 | Jonathan M. Craig | MD | Sale plan | 21,866 | $111.03 | $2.4M | Form 4 |
| Aug 13, 2026 | Dennis Howard | MD | Sale plan | 2,198 | $110.00 | $242K | Form 4 |
| Aug 12, 2026 | Charles R. Schwab | Chair | Sale | 46,410 | $108.18 | $5M | Form 4 |
| Aug 11, 2026 | Charles R. Schwab | Chair | Sale | 46,445 | $107.78 | $5M | Form 4 |
| Aug 10, 2026 | Nigel J Murtagh | Chief Risk Officer | Sale plan | 24,778 | $109.01 | $2.7M | Form 4 |
| Aug 7, 2026 | Paula A Sneed | Director | Sale | 5,263 | $107.15 | $564K | Form 4 |
| Aug 6, 2026 | Nigel J Murtagh | Chief Risk Officer | Sale plan | 1,897 | $109.00 | $207K | Form 4 |
| Aug 5, 2026 | Carolyn Schwab-Pomerantz | Director | Sale | 18,561 | $107.70 | $2M | Form 4 |
| Aug 5, 2026 | Jonathan M. Craig | MD | Sale plan | 21,750 | $107.02 | $2.3M | Form 4 |
| Aug 4, 2026 | Carolyn Schwab-Pomerantz | Director | Sale | 22,640 | $106.36 | $2.4M | Form 4 |
| Aug 4, 2026 | Charles R. Schwab | Chair | Sale | 47,650 | $106.08 | $5.1M | Form 4 |
| Aug 3, 2026 | Charles R. Schwab | Chair | Sale | 95,250 | $105.52 | $10.1M | Form 4 |
| Jul 29, 2026 | Charles R. Schwab | Chair | Sale | 95,450 | $105.82 | $10.1M | Form 4 |
| Jul 28, 2026 | Charles R. Schwab | Chair | Sale | 48,000 | $105.60 | $5.1M | Form 4 |
| Jul 28, 2026 | Carolyn Schwab-Pomerantz | Director | Sale | 22,650 | $105.71 | $2.4M | Form 4 |
| Jul 28, 2026 | Dennis Howard | MD | Sale plan | 28,000 | $105.01 | $2.9M | Form 4 |
| Jul 28, 2026 | Walter W Bettinger | Chair | Sale | 12,880 | $105.56 | $1.4M | Form 4 |
| Jul 28, 2026 | Walter W Bettinger | Chair | Sale | 38,263 | $105.18 | $4M | Form 4 |
| Jul 28, 2026 | Walter W Bettinger | Chair | Sale | 42,265 | $103.86 | $4.4M | Form 4 |
| Jul 27, 2026 | Walter W Bettinger | Chair | Sale | 192,488 | $103.90 | $20M | Form 4 |
| Jul 27, 2026 | Nigel J Murtagh | Chief Risk Officer | Sale plan | 11,000 | $104.03 | $1.1M | Form 4 |
| Jul 27, 2026 | Nigel J Murtagh | Chief Risk Officer | Sale plan | 21,947 | $104.00 | $2.3M | Form 4 |
| Jul 24, 2026 | Charles R. Schwab | Chair | Sale | 45,500 | $101.72 | $4.6M | Form 4 |
| Jul 23, 2026 | Peter J. Morgan III | General Counsel | Sale | 6,952 | $102.03 | $709K | Form 4 |
| Jul 21, 2026 | Nigel J Murtagh | Chief Risk Officer | Sale plan | 4,053 | $104.14 | $422K | Form 4 |
| Jul 21, 2026 | Jonathan S Beatty | MD | Sale plan | 2,000 | $104.21 | $208K | Form 4 |
| Jul 7, 2026 | Jonathan M. Craig | MD | Sale plan | 21,750 | $102.01 | $2.2M | Form 4 |
| Jul 7, 2026 | Jonathan S Beatty | MD | Sale plan | 2,000 | $102.01 | $204K | Form 4 |
| Jul 6, 2026 | Jonathan S Beatty | MD | Sale plan | 2,000 | $100.01 | $200K | Form 4 |
| Jul 2, 2026 | Jonathan S Beatty | MD | Sale plan | 2,000 | $97.03 | $194K | Form 4 |
| May 28, 2026 | Richard A Wurster | CEO | Purchase | 21,959 | $84.23 | $1.8M | Form 4 |
| May 19, 2026 | Charles R. Schwab | Chair | Sale | 27,500 | $92.22 | $2.5M | Form 4 |
| May 18, 2026 | Charles R. Schwab | Chair | Sale | 27,500 | $92.40 | $2.5M | Form 4 |
| May 13, 2026 | Arun Sarin | Director | Sale | 2,500 | $91.16 | $228K | Form 4 |
| May 6, 2026 | Charles R. Schwab | Chair | Sale | 109,300 | $92.01 | $10.1M | Form 4 |
| May 5, 2026 | Carolyn Schwab-Pomerantz | Director | Sale | 9,910 | $92.29 | $915K | Form 4 |
| May 4, 2026 | Charles R. Schwab | Chair | Sale | 109,300 | $91.50 | $10M | Form 4 |
| May 1, 2026 | Charles R. Schwab | Chair | Sale | 55,000 | $91.86 | $5.1M | Form 4 |
| Apr 30, 2026 | Charles R. Schwab | Chair | Sale | 50,000 | $91.81 | $4.6M | Form 4 |
| Apr 29, 2026 | Charles R. Schwab | Chair | Sale | 63,743 | $90.49 | $5.8M | Form 4 |
| Apr 28, 2026 | Frank C Herringer | Director | Sale | 2,520 | $90.60 | $228K | Form 4 |
| Apr 27, 2026 | Charles R. Schwab | Chair | Sale | 36,450 | $90.00 | $3.3M | Form 4 |
| Apr 23, 2026 | Charles R. Schwab | Chair | Sale | 36,450 | $90.50 | $3.3M | Form 4 |
| Apr 15, 2026 | Paul V Woolway | MD | Sale plan | 7,941 | $100.00 | $794K | Form 4 |
| Apr 14, 2026 | Paul V Woolway | MD | Sale plan | 7,942 | $98.00 | $778K | Form 4 |
| Apr 14, 2026 | Jonathan M. Craig | MD | Sale plan | 21,750 | $99.00 | $2.2M | Form 4 |
| Apr 14, 2026 | Nigel J Murtagh | Chief Risk Officer | Sale plan | 41,297 | $99.00 | $4.1M | Form 4 |
| Mar 3, 2026 | Nigel J Murtagh | Chief Risk Officer | Sale plan | 4,463 | $94.43 | $421K | Form 4 |
| Mar 3, 2026 | Nigel J Murtagh | Chief Risk Officer | Sale plan | 2,740 | $94.90 | $260K | Form 4 |
| Mar 3, 2026 | Jonathan M. Craig | MD | Sale plan | 5,449 | $94.89 | $517K | Form 4 |
| Mar 3, 2026 | Jonathan M. Craig | MD | Sale plan | 9,032 | $94.42 | $853K | Form 4 |
| Mar 3, 2026 | Dennis Howard | MD | Sale plan | 3,839 | $94.88 | $364K | Form 4 |
| Mar 3, 2026 | Dennis Howard | MD | Sale plan | 6,269 | $94.43 | $592K | Form 4 |
| Mar 3, 2026 | Paul V Woolway | MD | Sale plan | 2,500 | $94.89 | $237K | Form 4 |
| Mar 3, 2026 | Paul V Woolway | MD | Sale plan | 3,626 | $94.41 | $342K | Form 4 |
| Mar 2, 2026 | Paul V Woolway | MD | Sale plan | 7,942 | $96.00 | $762K | Form 4 |
| Mar 2, 2026 | Paul V Woolway | MD | Sale plan | 7,942 | $94.23 | $748K | Form 4 |
| Feb 27, 2026 | Jonathan S Beatty | MD | Sale | 2,030 | $95.30 | $193K | Form 4 |
| Feb 26, 2026 | Stephen A Ellis | Director | Sale | 10,725 | $96.57 | $1M | Form 4 |
| Feb 25, 2026 | Dennis Howard | MD | Sale plan | 27,903 | $95.02 | $2.7M | Form 4 |
| Feb 10, 2026 | Charles R. Schwab | Chair | Sale | 32,413 | $105.58 | $3.4M | Form 4 |
| Feb 9, 2026 | Charles R. Schwab | Chair | Sale | 126,200 | $106.55 | $13.4M | Form 4 |
| Feb 6, 2026 | Walter W Bettinger | Chair | Sale | 67,514 | $104.25 | $7M | Form 4 |
| Feb 6, 2026 | Christopher V Dodds | Director | Sale | 11,825 | $104.55 | $1.2M | Form 4 |
| Feb 4, 2026 | Charles R. Schwab | Chair | Sale | 67,975 | $103.81 | $7.1M | Form 4 |
| Feb 4, 2026 | Walter W Bettinger | Chair | Sale | 94,948 | $104.25 | $9.9M | Form 4 |
| Feb 3, 2026 | Charles R. Schwab | Chair | Sale | 96,625 | $103.74 | $10M | Form 4 |
| Feb 3, 2026 | Walter W Bettinger | Chair | Sale | 141,033 | $103.85 | $14.6M | Form 4 |
| Feb 3, 2026 | Walter W Bettinger | Chair | Sale | 21,429 | $104.24 | $2.2M | Form 4 |
| Feb 2, 2026 | Peter J. Morgan III | General Counsel | Sale | 7,595 | $104.38 | $793K | Form 4 |
| Jan 29, 2026 | Charles R. Schwab | Chair | Sale | 145,650 | $103.16 | $15M | Form 4 |
| Jan 28, 2026 | Charles R. Schwab | Chair | Sale | 26,475 | $103.22 | $2.7M | Form 4 |
| Jan 28, 2026 | Charles R. Schwab | Chair | Sale | 44,962 | $103.20 | $4.6M | Form 4 |
| Jan 26, 2026 | Charles R. Schwab | Chair | Sale | 134,895 | $103.09 | $13.9M | Form 4 |
| Jan 22, 2026 | Carolyn Schwab-Pomerantz | Director | Sale | 19,050 | $105.25 | $2M | Form 4 |
| Jan 22, 2026 | Carolyn Schwab-Pomerantz | Director | Sale | 4,765 | $105.02 | $500K | Form 4 |
| Jan 22, 2026 | Carolyn Schwab-Pomerantz | Director | Sale | 9,525 | $105.18 | $1M | Form 4 |
| Jan 22, 2026 | Carolyn Schwab-Pomerantz | Director | Sale | 9,525 | $105.19 | $1M | Form 4 |
| Jan 22, 2026 | Jonathan S Beatty | MD | Sale plan | 2,000 | $105.00 | $210K | Form 4 |
| Dec 23, 2025 | Jonathan S Beatty | MD | Sale plan | 2,000 | $102.01 | $204K | Form 4 |
Insiders by value traded
| Insider | Role | Bought | Sold | Last trade |
|---|---|---|---|---|
| Charles R. Schwab | Co-Chairman, Director | – | $201M | Nov 9, 2026 |
| Walter W Bettinger | Co-Chairman, Director | – | $91.8M | Aug 28, 2026 |
| Carolyn Schwab-Pomerantz | Director | – | $13.2M | Aug 26, 2026 |
| Nigel J Murtagh | Chief Risk Officer | – | $11.5M | Aug 10, 2026 |
| Jonathan M. Craig | MD, Head of Investor Services | – | $10.5M | Aug 14, 2026 |
| Dennis Howard | MD, Chief Tech, OPS & Data Off | – | $6.8M | Aug 13, 2026 |
| Paul V Woolway | MD, Chief Banking Officer | – | $3.7M | Apr 15, 2026 |
| Richard A Wurster | President & CEO, Director | $1.8M | – | May 28, 2026 |
| Neesha Hathi | MD, Head Wealth Adv, Bnk, Tst | – | $1.6M | Nov 2, 2026 |
| Jonathan S Beatty | MD, Head of Advisor Services | – | $1.5M | Aug 17, 2026 |
| Peter J. Morgan III | General Counsel | – | $1.5M | Jul 23, 2026 |
| Christopher V Dodds | Director | – | $1.2M | Feb 6, 2026 |
| Stephen A Ellis | Director | – | $1M | Feb 26, 2026 |
| Paula A Sneed | Director | – | $564K | Aug 7, 2026 |
| Frank C Herringer | Director | – | $228K | Apr 28, 2026 |
What this data shows, and what it doesn't
- Shows: open-market purchases and sales by officers, directors and 10%+ owners, reported on Form 4 within two business days of the trade.
- Leaves out: stock awards, option exercises, shares withheld for tax and gifts. These are not trades at a market price chosen by the insider.
- "plan" marks a sale made under a Rule 10b5-1 plan, a schedule set up in advance.
- Fund holders come from 13F reports, a snapshot at quarter end filed up to 45 days later.
- Filings are self-reported and can be amended. Each trade links to its original filing. Methodology
SCHW short interest
Low short interest. 1.1% of SCHW shares are sold short: about 1 share in 94. Over the last 12 reports the number of shares short went down 3%.
As a rough guide, under 5% is low, 5–10% is moderate, 10–20% is high and over 20% is very high.
As of Oct 30, 2026, 18.37M SCHW shares were sold short, 1.1% of the shares outstanding, up 8.2% from the report before. At the average daily volume of 8.98M shares, buying them all back would take about 2.0 trading days (days to cover).
Shares short, % of all shares
Days to cover
Every report
| Settlement date | Shares short | % of shares | Change | Avg daily volume | Days to cover |
|---|---|---|---|---|---|
| Oct 30, 2026 | 18.37M | 1.06% | +8% | 8.98M | 2.0 |
| Oct 15, 2026 | 16.98M | 0.98% | -11% | 8.12M | 2.1 |
| Sep 30, 2026 | 19.15M | 1.11% | -1% | 9.94M | 1.9 |
| Sep 15, 2026 | 19.31M | 1.12% | -9% | 6.90M | 2.8 |
| Aug 31, 2026 | 21.29M | 1.23% | +26% | 8.16M | 2.6 |
| Aug 14, 2026 | 16.85M | 0.97% | -18% | 6.60M | 2.5 |
| Jul 31, 2026 | 20.48M | 1.18% | -10% | 8.88M | 2.3 |
| Jul 15, 2026 | 22.67M | 1.30% | -9% | 8.45M | 2.7 |
| Jun 30, 2026 | 25.02M | 1.44% | +11% | 13.56M | 1.9 |
| Jun 15, 2026 | 22.63M | 1.30% | +8% | 11.06M | 2.0 |
| May 29, 2026 | 20.97M | 1.21% | +10% | 12.49M | 1.7 |
| May 15, 2026 | 19.01M | 1.09% | +15% | 9.98M | 1.9 |
Short sellers borrow shares and sell them, hoping to buy them back for less. A high number means many such bets are open. It does not say where the price will go. Source: FINRA equity short interest, reported by brokers twice a month (positions on the 15th and the last business day) and published about 7 business days later. % of shares uses the share count on the company's latest SEC filing. What short interest means · Most shorted stocks
Members of Congress who traded SCHW
Since Nov 17, 2024, 12 members of Congress reported 8 purchases and 11 sales of SCHW. The latest was a purchase by Alan Armstrong on Mar 30, 2026, reported Jul 21, 2026.
Purchases 8Sales 11
Reported trades
| Trade date | Member | Type | Amount | Owner | Reported | Source |
|---|---|---|---|---|---|---|
| Mar 30, 2026 | Alan Armstrong (R-OK) | Purchase | $1K–$15K | Self | Jul 21, 2026 | Report |
| Mar 27, 2026 | Alan Armstrong (R-OK) | Purchase | $1K–$15K | Self | Jul 21, 2026 | Report |
| Mar 27, 2026 | Gilbert Ray Cisneros, Jr. (D-CA) | Partial sale | $1K–$15K | Self | Apr 7, 2026 | Report |
| Jan 9, 2026 | Gilbert Ray Cisneros, Jr. (D-CA) | Purchase | $1K–$15K | Self | Feb 13, 2026 | Report |
| Dec 18, 2025 | Julie Johnson (D-TX) | Sale | $1K–$15K | Joint | Jan 15, 2026 | Report |
| Dec 11, 2025 | Dan Newhouse (R-WA) | Purchase | $1K–$15K | Spouse | Jan 15, 2026 | Report |
| Dec 10, 2025 | Gilbert Ray Cisneros, Jr. (D-CA) | Partial sale | $1K–$15K | Self | Jan 12, 2026 | Report |
| Nov 13, 2025 | Julie Johnson (D-TX) | Partial sale | $1K–$15K | Joint | Dec 11, 2025 | Report |
| Sep 23, 2025 | Val T. Hoyle (D-OR) | Sale | $1K–$15K | Spouse | Oct 10, 2025 | Report |
| Aug 14, 2025 | Julie Johnson (D-TX) | Partial sale | $1K–$15K | Joint | Sep 11, 2025 | Report |
| Jul 16, 2025 | Lisa C. McClain (R-MI) | Sale | $1K–$15K | Spouse | Aug 13, 2025 | Report |
| Jul 10, 2025 | Lisa C. McClain (R-MI) | Purchase | $1K–$15K | Spouse | Aug 13, 2025 | Report |
| Jul 10, 2025 | Rick W. Allen (R-GA) | Purchase | $15K–$50K | Spouse | Aug 11, 2025 | Report |
| May 12, 2025 | Jefferson Shreve (R-IN) | Sale | $15K–$50K | Self | Jun 22, 2025 | Report |
| May 5, 2025 | Marjorie Greene (GA) | Purchase | $1K–$15K | Self | May 6, 2025 | Report |
| Apr 21, 2025 | Bruce Westerman (R-AR) | Sale | $1K–$15K | Self | May 12, 2025 | Report |
| Apr 7, 2025 | Josh Gottheimer (D-NJ) | Purchase | $1K–$15K | Joint | May 14, 2025 | Report |
| Mar 19, 2025 | Sheri Biggs (R-SC) | Sale | $15K–$50K | Spouse | Oct 5, 2025 | Report |
| Feb 21, 2025 | Josh Gottheimer (D-NJ) | Partial sale | $1K–$15K | Joint | Mar 6, 2025 | Report |
Source: Periodic Transaction Reports filed with the Clerk of the House and the Secretary of the Senate under the STOCK Act. Members report each trade within 45 days, as a dollar range, not an exact amount. Trades by a spouse or dependent child are included and marked. Paper filings (scanned images) are not included, and Senate reports are shown for current senators only. Links to Senate reports open the Senate’s own site, which shows its terms first and can only be reached from the United States. How these reports work
Schwab Charles company events
Schwab Charles filed 12 reports on Form 8-K in the last 12 months, 1 of them about an important change (leadership). The latest was on Oct 15, 2026.
- Oct 15, 2026ResultsReleased financial results. Filing
- Aug 12, 2026AnnouncementThe Charles Schwab Corporation issued $1.25 billion of 5.108% Fixed-to-Floating Rate Senior Notes due 2032 and $1.35 billion of 5.655% Fixed-to-Floating Rate Senior Notes due 2037. Filing
- Jul 21, 2026ResultsReleased financial results. Filing
- Jun 29, 2026AnnouncementThe Charles Schwab Corporation issued $1 billion of 4.603% Fixed-to-Floating Rate Senior Notes due 2029. Filing
- Jun 1, 2026RulesChanged its bylaws or articles. Filing
- May 22, 2026VoteReported shareholder vote results. Filing
- May 21, 2026AnnouncementThe Charles Schwab Corporation issued $1 billion of 4.744% Fixed-to-Floating Rate Senior Notes due 2030 and $1.25 billion of 5.493% Fixed-to-Floating Rate Senior Notes due 2037. Filing
- Apr 22, 2026AnnouncementIn connection with the Preferred Issuance, CSC entered into an Underwriting Agreement with Citigroup Global Markets Inc., Goldman Sachs & Co. LLC, J.P. Morgan Securities LLC, Morgan Stanley & Co. LLC, TD Securities (USA) LLC and Wells Fargo Securities, LLC, as the representatives of the several… Filing
- Apr 16, 2026ResultsReleased financial results. Filing
- Mar 2, 2026AnnouncementShared information with investors. Filing
- Jan 29, 2026LeadershipThe Board of Directors of The Charles Schwab Corporation appointed Dennis Howard as Managing Director, Chief Technology, Operations and Data Officer of the Company, effective immediately. Filing
- Jan 21, 2026ResultsReleased financial results. Filing
From 8-K reports, which a company must file within 4 business days of an important event. Where a report is about a change such as a new CEO, the sentence is the first one from the report itself, shortened. Each row links to the original filing. Company events this week
How Schwab Charles makes money
Investor Services brought in 79% of Schwab Charles's revenue ($19B of $23.9B) in 2025. Advisor Services was next, at 21%.
By business segment, 2025
From Schwab Charles's annual report (10-K) for the year ended Dec 31, 2025, filed Feb 25, 2026. The company chooses how to group its revenue, so the parts differ from one company to the next. Read the filing · How the biggest companies make money
Schwab Charles financials
Famous investors that hold SCHW
11 of the 50 well-known investors we track reported holding SCHW in their latest 13F filing. The largest position is Bill Nygren's, worth $2.3B.
Position size
All holders
| Fund | Quarter | Shares | Value | Of portfolio | Change |
|---|---|---|---|---|---|
| Bill Nygren · Harris Associates (Oakmark) | Q3 2026 | 23.35M | $2.3B | 3.0% | -4% |
| Ken Fisher · Fisher Asset Management | Q3 2026 | 21.94M | $2.1B | 0.6% | No change |
| Jim Simons · Renaissance Technologies | Q3 2026 | 4.28M | $419M | 0.6% | +124% |
| Steve Cohen · Point72 Asset Management | Q3 2026 | 2.19M | $214M | 0.4% | +340% |
| Ken Griffin · Citadel Advisors | Q3 2026 | 1.93M | $189M | 0.1% | -43% |
| Israel Englander · Millennium Management | Q3 2026 | 1.45M | $141M | 0.1% | +16% |
| Tom Gayner · Markel Group | Q3 2026 | 1.39M | $136M | 1.1% | No change |
| Dan Sundheim · D1 Capital Partners | Q3 2026 | 1.35M | $132M | 0.4% | -45% |
| Ray Dalio · Bridgewater Associates | Q3 2026 | 53,914 | $5.3M | 0.0% | +88% |
| Lee Ainslie · Maverick Capital | Q3 2026 | 10,525 | $1M | 0.0% | New |
| Edgar Wachenheim · Greenhaven Associates | Q3 2026 | 10,500 | $1M | 0.0% | -16% |
From 13F reports: a snapshot at quarter end, filed up to 45 days later. Change compares with the quarter before.
Questions about Schwab Charles Corp (SCHW) stock
Who owns the most SCHW stock?
The largest reported owner of Schwab Charles Corp (SCHW) is BlackRock, Inc., with 7.7% of the company. In total, 2,297 funds and institutions reported holding SCHW at the end of Q2 2026, together about 83% of the shares. See the largest owners.
Are SCHW insiders buying or selling?
In the last 12 months, SCHW insiders reported 1 open-market purchase worth $1.8M and 92 sales worth $347M. The latest trade was on Nov 9, 2026. See every trade.
What is the short interest in SCHW?
As of Oct 30, 2026, 18.37M SCHW shares were sold short, 1.1% of the shares outstanding, up 8.2% from the report before. At the average daily volume of 8.98M shares, buying them all back would take about 2.0 trading days (days to cover). See the history.
Have members of Congress traded SCHW?
Yes. 12 members of Congress reported 8 purchases and 11 sales of SCHW since Nov 17, 2024. The latest was reported on Jul 21, 2026. See the trades.
How does Schwab Charles make money?
Investor Services brought in 79% of Schwab Charles's revenue ($19B of $23.9B) in 2025. Advisor Services was next, at 21%. See the full split.
Which famous investors hold SCHW?
11 of the 50 well-known investors we track reported SCHW in their latest 13F filing, including Bill Nygren, Ken Fisher, Jim Simons. The largest position is worth $2.3B. See all holders.
Executive pay
Schwab Charles's chief executive was paid a total of $18.8M for the year ended Dec 31, 2025, down 29% from $26.4M the year before. In the last 12 months, Schwab Charles's executives and directors bought $1.8M of stock on the open market and sold $347M.
From the pay versus performance table in the company's annual proxy statement (DEF 14A), as the company reported it. If the chief executive changed during the year, the company reports each person separately and this shows one of them.
Source: SEC Form 4 (insiders, filed within 2 business days), 13F (funds, up to 45 days after quarter end) and Schedule 13D/13G filings. Only open-market purchases (code P) and sales (code S) are shown. Data only, not investment advice. How we collect it.